What is Genomics worth?
$161.6Mlast known valuation
Free account
More of Genomics with a free account
- ·The complete investor list: 16 names
- ·Watch Genomics: the Monday email on marks, rounds and moves
Genomics funding history
No rounds on record
No funding rounds for Genomics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
Genomics valuation
Genomics's last known valuation is $162 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How Genomics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Genomics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Genomics
- What is Genomics worth?
- Genomics's last known valuation is $161.6M.
- How much has Genomics raised?
- Genomics has raised $142.2M in total funding across its recorded rounds.